Mechanisms of colorectal and lung cancer prevention by vegetables: a genomic approach

Journal of Nutritional Biochemistry

Volumn 19, Issue 3, 2008, Pages 139-157

  van Breda, Simone G J ^a   de Kok, Theo M C M ^a   van Delft, Joost H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chemoprevention; Colorectal cancer; Genomics; Lung cancer; Mechanisms; Vegetables

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; APIGENIN; ASCORBIC ACID; BETA CAROTENE; BETA NAPHTHOFLAVONE; CAROTENOID; DIALYL DISULFIDE; DIALYL SULFIDE; DIPROPYL DISULFIDE; DIPROPYL SULFIDE; FLAVONE; FLAVONOID; GENISTEIN; GLUCORAPHANIN; INDOLE DERIVATIVE; ISOFLAVONE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; KAEMPFEROL; OLTIPRAZ; ORGANOSULFUR DERIVATIVE; PHENETHYL ISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; PROTEINASE INHIBITOR; QUERCETIN; RETINOL; SELENIUM; SULFORAPHANE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; BIOTRANSFORMATION; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CYTOCHROME P450 1A1 GENE; CYTOCHROME P450 2D6 GENE; GENE; GENE EXPRESSION; GENE MUTATION; GENETICS; GENOME ANALYSIS; GENOMICS; GLUTATHIONE S TRANSFERASE MU GENE; HUMAN; HUMAN MUTL HOMOLOG 1 GENE; HUMAN MUTS HOMOLOG 2 GENE; HUMAN MUTS HOMOLOG 3 GENE; HUMAN MUTS HOMOLOG 6 GENE; HUMAN POSTMEIOTIC SEGREGATION 1 GENE; HUMAN POSTMEIOTIC SEGREGATION 2 GENE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MISMATCH REPAIR GENE; NONHUMAN; ONCOGENE K RAS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; VEGETABLE; WISP 1 GENE; WISP 3 GENE;

APOPTOSIS; CELL CYCLE; CELL DIVISION; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; VEGETABLES;

ANIMALIA;

EID: 38849204227     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.04.002     Document Type: Review

References (147)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective (1997) Washington: BANTA Book Group; 1997
2. World Health Organization, and International Agency for Research on Cancer. World cancer report (2003), IARC Press, Lyon
3. Willett W.C. Diet, nutrition, and avoidable cancer. Environ Health Perspect 103 Suppl 8 (1995) 165-170
4. Troisi R.J., Freedman A.N., and Devesa S.S. Incidence of colorectal carcinoma in the US: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 85 (1999) 1670-1676
5. Parkin D.M. Epidemiology of cancer: global patterns and trends. Toxicol Lett 102-103 (1998) 227-234
6. World Cancer Research Fund/American Institute for Cancer Research. Chapter 4.10: In: Cannon G, editor. Colon, rectum. Food, nutrition and the prevention of cancer: a global perspective (1997), BANTA Book Group, Washington 216-251
7. Potter J.D. Colorectal cancer: molecules and populations. J Natl Cancer Inst 91 (1999) 916-932
8. Bruce W.R., Giacca A., and Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 1271-1279
9. Doll R., and Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66 (1981) 1191-1308
10. van't Veer P., Jansen M.C., Klerk M., and Kok F.J. Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr 3 (2000) 103-107
11. Lynch H.T., and de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 348 (2003) 919-932
12. Syngal S., Clarke G., and Bandipalliam P. Potential roles of genetic biomarkers in colorectal cancer chemoprevention. J Cell Biochem Suppl 34 (2000) 28-34
13. Levin B. Genetic syndromes as potential targets for chemoprevention of colorectal neoplasia. J Cell Biochem Suppl 34 (2000) 19-22
14. World Health Organization, and International Agency for Research on Cancer. World cancer report (2003), IARC Press, Lyon
15. World Cancer Research Fund/American Institute for Cancer Research. Chapter 4.5: Lung. In: Cannon G, editor. Food, nutrition and the prevention of cancer: a global perspective (1997), BANTA Book Group, Washington 130-147
16. Alberg A.J., and Samet J.M. Epidemiology of lung cancer. Chest 123 (2003) 21S-49S
17. Omenn G.S. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health 19 (1998) 73-99
18. Ziegler R.G., Mayne S.T., and Swanson C.A. Nutrition and lung cancer. Cancer Causes Control 7 (1996) 157-177
19. Fong K.M., and Minna J.D. Molecular biology of lung cancer: clinical implications. Clin Chest Med 23 (2002) 83-101
20. You M., and Bergman G. Preclinical and clinical models of lung cancerchemoprevention. Hematol Oncol Clin North Am 12 (1998) 1037-1053
21. Szabo E., and Mulshine J. Epidemiology, prognostic factors, and prevention of lung cancer. Curr Opin Oncol 5 (1993) 302-309
22. Ooi W.L., Elston R.C., Chen V.W., Bailey-Wilson J.E., and Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 76 (1986) 217-222
23. Sellers T.A., Bailey-Wilson J.E., Elston R.C., Wilson A.F., Elston G.Z., Ooi W.L., et al. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82 (1990) 1272-1279
24. Vineis P., Malats N., Lang A., d'Errico A., Caporaso N., Cuzick J., et al. Metabolic polymorphisms and susceptibility to cancer: Lyon: IARC Scientific Publications No. 148 (1999)
25. Spivack S.D., Fasco M.J., Walker V.E., and Kaminsky L.S. The molecular epidemiology of lung cancer. Crit Rev Toxicol 27 (1997) 319-365
26. Fearon E.R., and Jones P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J 6 (1992) 2783-2790
27. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
28. Fujiwara T., Stolker J.M., Watanabe T., Rashid A., Longo P., Eshleman J.R., et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 153 (1998) 1063-1078
29. Grady W.M., and Markowitz S.D. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3 (2002) 101-128
30. Ilyas M., Straub J., Tomlinson I.P., and Bodmer W.F. Genetic pathways in colorectal and other cancers. Eur J Cancer 35 (1999) 335-351
31. Chung D.C. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119 (2000) 854-865
32. Arends J.W. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 190 (2000) 412-416
33. Zochbauer-Muller S., Gazdar A.F., and Minna J.D. Molecular pathogenesis of lung cancer. Annu Rev Physiol 64 (2002) 681-708
34. Sekido Y., Fong K.M., and Minna J.D. Molecular genetics of lung cancer. Annu Rev Med 54 (2003) 73-87
35. Sanchez-Cespedes M. Dissecting the genetic alterations involved in lung carcinogenesis. Lung Cancer 40 (2003) 111-121
36. Potter J.D. Cancer prevention: epidemiology and experiment. Cancer Lett 114 (1997) 7-9
37. World Cancer Research Fund/American Institute for Cancer Research. Chapter 6.3: Vegetables and fruits. In: Cannon G, editor: Food, nutrition and the prevention of cancer: a global perspective (1997), BANTA Book Group, Washington 436-446
38. Greenwald P., Clifford C.K., and Milner J.A. Diet and cancer prevention. Eur J Cancer 37 (2001) 948-965
39. Steinmetz K.A., and Potter J.D. Vegetables, fruit, and cancer: II. Mechanisms. Cancer Causes Control 2 (1991) 427-442
40. Temple N.J., and Kaiser Gladwin K. Fruit, vegetables, and the prevention of cancer. Research challenges. Nutrition 19 (2003) 467-470
41. Manson M.M., Gescher A., Hudson E.A., Plummer S.M., Squires M.S., and Prigent S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol Lett 112-113 (2000) 499-505
42. Steele V.E., Boone C.W., Lubet R.A., Crowell J.A., Holmes C.A., Sigman C.C., et al. Preclinical drug development paradigms for chemopreventives. Hematol Oncol Clin North Am 12 (1998) 943-961 v--vi
43. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat Res 402 (1998) 151-158
44. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Boone C.W., Malone W.A., et al. Progress in cancer chemoprevention. Ann N Y Acad Sci 889 (1999) 1-13
45. Dragsted L.O., Strube M., and Larsen J.C. Cancer-protective factors in fruits and vegetables: biochemical and biological background. Pharmacol Toxicol 72 (1993) 116-135
46. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52 (1992) 2085s-2091s
47. Wenzel U., Kuntz S., Brendel M.D., and Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60 (2000) 3823-3831
48. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M.A., Chevolleau S., et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60 (2000) 1426-1433
49. Bonnesen C., Eggleston I.M., and Hayes J.D. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61 (2001) 6120-6130
50. Palozza P., Serini S., Maggiano N., Angelini M., Boninsegna A., Di Nicuolo F., et al. Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by beta-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23 (2002) 11-18
51. Hu R., Kim B.R., Chen C., Hebbar V., and Kong A.N. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24 (2003) 1361-1367
52. Neave A.S., Sarup S.M., Seidelin M., Duus F., and Vang O. Characterization of the N-methoxyindole-3-carbinol (NI3C)-induced cell cycle arrest in human colon cancer cell lines. Toxicol Sci 83 (2005) 126-135
53. 1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57 (2006) 317-327
54. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C., et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21 (2000) 921-927
55. Vang O., Jensen H., and Autrup H. Induction of cytochrome P-450IA1, IA2, IIB1, IIB2 and IIE1 by broccoli in rat liver and colon. Chem Biol Interact 78 (1991) 85-96
56. Clapper M.L., Szarka C.E., Pfeiffer G.R., Graham T.A., Balshem A.M., Litwin S., et al. Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clin Cancer Res 3 (1997) 25-30
57. Guyonnet D., Siess M.H., Le Bon A.M., and Suschetet M. Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Toxicol Appl Pharmacol 154 (1999) 50-58
58. Nijhoff W.A., Grubben M.J., Nagengast F.M., Jansen J.B., Verhagen H., van Poppel G., et al. Effects of consumption of brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis 16 (1995) 2125-2128
59. Herzog A., Kindermann B., Doring F., Daniel H., and Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics 4 (2004) 2455-2464
60. van Erk M.J., Roepman P., van der Lende T.R., Stierum R.H., Aarts J.M., van Bladeren P.J., et al. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44 (2005) 143-156
61. Breikers G., van Breda S.G., Bouwman F.G., van Herwijnen M.H., Renes J., Mariman E.C., et al. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis. Proteomics 6 (2006) 2844-2852
62. Banoub R.W., Fernstrom M., and Ruch R.J. Lack of growth inhibition or enhancement of gap junctional intercellular communication and connexin43 expression by beta-carotene in murine lung epithelial cells in vitro. Cancer Lett 108 (1996) 35-40
63. 1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett 437 (1998) 61-64
64. 2/M arrest and induction of apoptosis. Drug Metab Dispos 34 (2006) 296-304
65. Paolini M., Perocco P., Canistro D., Valgimigli L., Pedulli G.F., Iori R., et al. Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNA-damaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoli. Carcinogenesis 25 (2004) 61-67
66. Izzotti A., Bagnasco M., Cartiglia C., Longobardi M., Camoirano A., Tampa E., et al. Modulation of multigene expression and proteome profiles by chemopreventive agents. Mutat Res 591 (2005) 212-223
67. van Breda S.G., van Agen E., van Sanden S., Burzykowski T., Kleinjans J.C., and Delft J.H. Vegetables affect the expression of genes involved in carcinogenic and anticarcinogenic processes in the lungs of female C57BL/6 mice. J Nutr 135 (2005) 2546-2552
68. Ranelletti F.O., Maggiano N., Serra F.G., Ricci R., Larocca L.M., Lanza P., et al. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer 85 (2000) 438-445
69. Powolny A., Takahashi K., Hopkins R.G., and Loo G. Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells. J Cell Biochem 90 (2003) 1128-1139
70. Murtaza I., Marra G., Schlapbach R., Patrignani A., Kunzli M., Wagner U., et al. A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnol Appl Biochem 45 (2006) 29-36
71. Kallay E., Adlercreutz H., Farhan H., Lechner D., Bajna E., Gerdenitsch W., et al. Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr 132 (2002) 3490S-3493S
72. van Breda S.G., van Agen E., van Sanden S., Burzykowski T., Kienhuis A.S., Kleinjans J.C., et al. Vegetables affect the expression of genes involved in anticarcinogenic processes in the colonic mucosa of C57BL/6 female mice. J Nutr 135 (2005) 1879-1888
73. Mori H., Tanaka T., Sugie S., Yoshimi N., Kawamori T., Hirose Y., et al. Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J Cell Biochem Suppl 27 (1997) 35-41
74. van Kranen H.J., van Iersel P.W., Rijnkels J.M., Beems D.B., Alink G.M., and van Kreijl C.F. Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the ApcMin mouse. Carcinogenesis 19 (1998) 1597-1601
75. Kato T., Hancock R., Mohammadpour H., McGregor B., Manalo P., Khaiboullina S., et al. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 187 (2002) 169
76. Kim D.J., Shin D.H., Ahn B., Kang J.S., Nam K.T., Park C.B., et al. Chemoprevention of colon cancer by Korean food plant components. Mutat Res 523-524 (2003) 99-107
77. Rijken P.J., Timmer W.G., van de Kooij A.J., van Benschop I.M., Wiseman S.A., Meijers M., et al. Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis 20 (1999) 2267-2272
78. van Breda S.G., van Agen E., Engels L.G., Moonen E.J., Kleinjans J.C., and van Delft J.H. Altered vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from adenoma patients and controls. Carcinogenesis 25 (2004) 2207-2216
79. Faivre J., Couillault C., and Belghiti C. Intervention trials on colorectal cancer prevention. IARC Sci Publ (1996) 115-124
80. MacLennan R., Macrae F., Bain C., Battistutta D., Chapuis P., Gratten H., et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project [see comments]. J Natl Cancer Inst 87 (1995) 1760-1766
81. Schatzkin A., Lanza E., Corle D., Lance P., Iber F., Caan B., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group [see comments]. N Engl J Med 342 (2000) 1149-1155
82. Omenn G.S., Goodman G., Thornquist M., Grizzle J., Rosenstock L., Barnhart S., et al. The Beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54 (1994) 2038s-2043s
83. Kelley M.J., and McCrory D.C. Prevention of lung cancer: summary of published evidence. Chest 123 (2003) 50S-59S
84. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330 (1994) 1029-1035
85. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. Chapter 17: The cell cycle and programmed cell death. Molecular biology of the cell (2002), Garland Science, New York 983-1026
86. Johnson I.T. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem Toxicol 40 (2002) 1171-1178
87. Kamada S., Washida M., Hasegawa J., Kusano H., Funahashi Y., and Tsujimoto Y. Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway. Oncogene 15 (1997) 285-290
88. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106 (2000) 1127-1137
89. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., and Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18 (1998) 6353-6364
90. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153 (2001) 999-1010
91. Hall A.K. Thymosin beta-10 accelerates apoptosis. Cell Mol Biol Res 41 (1995) 167-180
92. Santelli G., Califano D., Chiappetta G., Vento M.T., Bartoli P.C., Zullo F., et al. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 155 (1999) 799-804
93. Xu X., Fu X.Y., Plate J., and Chong A.S. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 58 (1998) 2832-2837
94. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432 (1999) 159-184
95. Lee H.Y., Chun K.H., Liu B., Wiehle S.A., Cristiano R.J., Hong W.K., et al. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 62 (2002) 3530-3537
96. Ali O., Cohen P., and Lee K.W. Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Horm Metab Res 35 (2003) 726-733
97. Griffin M., Casadio R., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem J 368 (2002) 377-396
98. Ma Y., Koza-Taylor P.H., DiMattia D.A., Hames L., Fu H., Dragnev K.H., et al. Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene 22 (2003) 4924-4932
99. Zhang H., Heim J., and Meyhack B. Novel BNIP1 variants and their interaction with BCL2 family members. FEBS Lett 448 (1999) 23-27
100. Yasuda M., and Chinnadurai G. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1. Oncogene 19 (2000) 2363-2367
101. Bonner A.E., Lemon W.J., Devereux T.R., Lubet R.A., and You M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 23 (2004) 1166-1176
102. Niesink M., de Vries J., and Hollinger M.A. Toxicology: principles and applications (1996), CRC Press, Boca Raton (Fla)
103. van Iersel M.L., Verhagen H., and van Bladeren P.J. The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res 443 (1999) 259-270
104. Gamage N.U., Duggleby R.G., Barnett A.C., Tresillian M., Latham C.F., Liyou N.E., et al. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 278 (2003) 7655-7662
105. Wong C.F., Liyou N., Leggett B., Young J., Johnson A., and McManus M.E. Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 29 (2002) 754-758
106. Kadlubar F., Kaderlik R.K., Mulder G.J., Lin D., Butler M.A., Teitel C.H., et al. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. Princess Takamatsu Symp 23 (1995) 207-213
107. Turesky R.J. Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab Rev 34 (2002) 625-650
108. Morel F., Schulz W.A., and Sies H. Gene structure and regulation of expression of human glutathione S-transferases alpha. Biol Chem Hoppe Seyler 375 (1994) 641-649
109. Yang Y., Sharma R., Zimniak P., and Awasthi Y.C. Role of alpha class glutathione S-transferases as antioxidant enzymes in rodent tissues. Toxicol Appl Pharmacol 182 (2002) 105-115
110. Liang G., Miao X., Zhou Y., Tan W., and Lin D. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 25 (2004) 773-778
111. Martinez C., Garcia-Martin E., Ladero J.M., Sastre J., Garcia-Gamito F., Diaz-Rubio M., et al. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. Carcinogenesis 22 (2001) 1323-1326
112. Snyderwine E.G., Turesky R.J., Turteltaub K.W., Davis C.D., Sadrieh N., Schut H.A., et al. Metabolism of food-derived heterocyclic amines in nonhuman primates. Mutat Res 376 (1997) 203-210
113. Jacobs L.R. Fiber and colon cancer. Gastroenterol Clin North Am 17 (1988) 747-760
114. Bartsch H., Ohshima H., and Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat Res 202 (1988) 307-324
115. Lampe J.W., and Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 132 (2002) 2991-2994
116. van Poppel G., Verhoeven D.T., Verhagen H., and Goldbohm R.A. Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 472 (1999) 159-168
117. Smith T.J., and Yang C.S. Effect of organosulfur compounds from garlic and cruciferous vegetables on drug metabolism enzymes. Drug Metabol Drug Interact 17 (2000) 23-49
118. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., and van Leeuwen P.A. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74 (2001) 418-425
119. Ross J.A., and Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22 (2002) 19-34
120. Bianchini F., and Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer?. Environ Health Perspect 109 (2001) 893-902
121. Verhoeven D.T., Verhagen H., Goldbohm R.A., van den Brant P.A., and van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 103 (1997) 79-129
122. Murillo G., and Mehta R.G. Cruciferous vegetables and cancer prevention. Nutr Cancer 41 (2001) 17-28
123. Awasthi Y.C., Singhal S.S., and Awasthi S. Mechanisms of anticarcinogenic effects of antioxidant nutrients. In: Watson R.R., and Mufti S.I. (Eds). Nutrition and cancer prevention (1996), CRC Press, Boca Raton (Fla) 139-172
124. Collins A.R., Olmedilla B., Southon S., Granado F., and Duthie S.J. Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 19 (1998) 2159-2162
125. van Poppel G., and Goldbohm R.A. Epidemiologic evidence for beta-carotene and cancer prevention. Am J Clin Nutr 62 (1995) 1393S-1402S
126. De Flora S., Zanacchi P., Izotti H., and Hayatsu H. Mechanisms of food-borne inhibitors of genotoxicity relevant to cancer prevention. In: Hayatsu H. (Ed). Mutagens in food. Detection and prevention (1991), CRC Press, Boca Raton 157-180
127. Dutta A., and Dutta S.K. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 22 (2003) 258-268
128. Troll W., Wiesner R., and Frenkel K. Anticarcinogenic action of protease inhibitors. Adv Cancer Res 49 (1987) 265-283
129. Deschner E.E., Ruperto J., Wong G., and Newmark H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12 (1991) 1193-1196
130. Adams J. Proteasome inhibition: a novel approach to cancer therapy. Trends Mol Med 8 (2002) S49-S54
131. Frommel T.O., Mobarhan S., Doria M., Halline A.G., Luk G.D., Bowen P.E., et al. Effect of beta-carotene supplementation on indices of colonic cell proliferation. J Natl Cancer Inst 87 (1995) 1781-1787
132. Phillips R.W., Kikendall J.W., Luk G.D., Willis S.M., Murphy J.R., Maydonovitch C., et al. Beta-carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Res 53 (1993) 3723-3725
133. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273 (1998) 3838-3847
134. McBurney M.W., Costa S., and Pratt M.A. Retinoids and cancer: a basis for differentiation therapy. Cancer Invest 11 (1993) 590-598
135. Ren W., Qiao Z., Wang H., Zhu L., and Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 23 (2003) 519-534
136. Honma Y., Okabe-Kado J., Kasukabe T., Hozumi M., and Umezawa K. Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells. Jpn J Cancer Res 81 (1990) 1132-1136
137. Bertram J.S. Carotenoids and gene regulation. Nutr Rev 57 (1999) 182-191
138. Bertram J.S., and Bortkiewicz H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 62 (1995) 1327S-1336S
139. Schelp F.P., and Pongpaew P. Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors - a hypothesis. Int J Epidemiol 17 (1988) 287-292
140. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Siber G., Loszewski R., et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277 (1997) 1380-1386
141. Siegel B.V. Enhancement of interferon production by poly(rI)-poly(rC) in mouse cell cultures by ascorbic acid. Nature 254 (1975) 531-532
142. Reifen R. Vitamin A as an anti-inflammatory agent. Proc Nutr Soc 61 (2002) 397-400
143. Hughes D.A. Effects of carotenoids on human immune function. Proc Nutr Soc 58 (1999) 713-718
144. Michnovicz J.J., and Bradlow H.L. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 16 (1991) 59-66
145. Messina M., and Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83 (1991) 541-546
146. Tosetti F., Ferrari N., De Flora S., and Albini A. Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16 (2002) 2-14
147. Meng Q., Qi M., Chen D.Z., Yuan R., Goldberg I.D., Rosen E.M., et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med 78 (2000) 155-165